Navigation Links
Early Stage Commercialization: Keys to Successful New Product Launch
Date:7/7/2011

CHAPEL HILL, N.C., July 7, 2011 /PRNewswire/ -- Expensive drug development processes, rising competition and evolving market needs are leading biopharmaceutical companies into implementing commercialization strategies earlier and earlier into the new product development process. In fact, Best Practices, LLC, study, Pharmaceutical New Product Commercialization: Preparing for Market Success (click link to download complimentary research excerpt), reveals that 61% of benchmarked companies begin early stage commercialization activities in at least one functional area during the pre-clinical phase.

The report also shares the insights on why the work done through early stage commercialization group is invaluable and how other biopharmaceutical companies' Early Stage Commercialization functions are structured, how leaders of these groups manage their functions, and for what activities and role Early-Stage Commercialization leaders have responsibility.

Interviews and key insights in this study are drawn from leaders at 20 different biopharmaceutical companies, including Abbott, Amgen, Bayer, Eli Lilly, GlaxoSmithKline, Novartis and Shire. This Best Practices, LLC benchmarking study identifies winning strategies, structures, and best practices in early-stage product commercialization and portfolio management.

The full 85-page report contains more than 75 metrics and scores of narratives that companies can use to improve early-stage decision making and enhance product design to gain an overall competitive advantage in the marketplace. Key topics of this primary research include:

  • Optimizing the value of assets
  • Driving alignment of product development with unmet patient needs
  • Identifying commercial viability of drug candidates and helping to redirect funding from projects with lower potential to those with higher potential for success
  • Focusing all parties on areas expected to have the greatest return on investment
  • Enabling project prioritization
  • Facilitating collaboration between commercial and clinical development staff
  • Informing internal and external investment decisions
  • Continuously monitoring and communicating changes in the market that affect product potential
  • Paving the way for successful product launch

To learn more about the study, download a complimentary summary at http://www.best-in-class.com/rr1057.htm

For more information, contact Cameron Tew, Executive Director of Research and Publishing at Best Practices, LLC at (919) 767-9246 or ctew@best-in-class.com.

BEST PRACTICES, LLC conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer
2. CT Scans Unleash a Breakthrough in Catching Early Stage Lung Cancer
3. Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent® Drug-Eluting Coronary Stent Based on Early Clinical Data
4. Renowned Experts to Share Early Insights Into Why Bariatric Surgery Improves Type 2 Diabetes for Many Patients
5. Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery
6. PRA Early Phase Leaders to Speak at Bioanalysis Forum
7. FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System
8. Kendle Appoints Pierre Geoffroy, MD, CM, MSc, FCFP Vice President, Early Stage
9. MD Anderson and Biocept Scientists to Present Poster at ASCO on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breast Cancer Patients
10. Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment
11. Abstracts Reporting EarlyCDT™-Lung Demonstrate Diagnostic and Economic Benefits of Immuno-biomarkers in Early Detection of Solid Tumor Lung Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Research and Markets has announced the addition of the ... Insight 2022" drug pipelines to their offering. ... Global Immune ... gives comprehensive insight on clinical and non-clinical aspects involved in ... main streamline drugs in the immunotherapy treatment. Report helps to ...
(Date:3/22/2017)... Mar 22, 2017 Research and Markets has ... & Trends - Industry Forecast to 2025" report to their ... The ... of around 7.1% over the next decade to reach approximately $129.81 ... estimates and forecasts for all the given segments on global as ...
(Date:3/22/2017)... , March 22, 2017  Applied BioMath ( ... to drug research and development, today announced the ... QSP Day 2017 is a day full of ... systems pharmacology (QSP) community. The focus is to ... de-risking and accelerating drug research and development. ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... GeBBS Healthcare Solutions unveils ... HCCA’s 21st annual Compliance Institute on March 26-28 in National Harbor, Maryland. ... medical chart types with a comprehensive set of features including built-in workflow, interactive ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... “Wounded Woman ... “Wounded Woman Be Ye Healed-Passing On A Legacy” is the creation of published author, ... founder of Comfortbearers grief ministry. She has been happily married to her husband, ...
(Date:3/23/2017)... ... March 23, 2017 , ... “A Respectful Response To Atheist ... To Atheist Manifesto” is the creation of published author Richard Hostetter, a former ... years. He holds graduate degrees from Kent State University and the University of ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... today announced the publication of “Profiling protein expression in circulating tumor cells using ... publication describes the use of the Vortex technology to capture CTCs ...
(Date:3/22/2017)... ... March 23, 2017 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... Convention, currently taking place at the Suntec Singapore International Exhibition & Convention Centre, ...
Breaking Medicine News(10 mins):